Published in Am J Psychiatry on September 01, 1988
Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry (1990) 1.17
Cobalamin deficiency, hyperhomocysteinemia, and dementia. Neuropsychiatr Dis Treat (2010) 0.94
Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease. Drugs (1990) 0.93
Influence of S-adenosyl-L-methionine on chronic mild stress-induced anhedonia in castrated rats. Br J Pharmacol (1999) 0.87
A Case Report of a Manic Episode Triggered by S-Adenosylmethionine (SAMe). Prim Care Companion J Clin Psychiatry (2002) 0.85
S-adenosylmethionine (SAM-e) for the treatment of depression in people living with HIV/AIDS. BMC Psychiatry (2004) 0.83
The effect of methylated vitamin B complex on depressive and anxiety symptoms and quality of life in adults with depression. ISRN Psychiatry (2013) 0.79
S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research. J Clin Psychiatry (2017) 0.75
Reimmunization Against Diphtheria of Previously Immunized Children. Am J Public Health Nations Health (1942) 7.70
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry (1995) 7.19
Diphtheria Immunization with Fluid Toxoid and Alum-Precipitated Toxoid. Am J Public Health Nations Health (1942) 3.95
Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull (1982) 3.63
A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry (1982) 2.75
Comparative Speed of Response of Previously Immunized and Non-Immunized Children to Fluid and Alum-Precipitated Diphtheria Toxoid. Am J Public Health Nations Health (1943) 2.49
The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry (1990) 2.41
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci U S A (2005) 2.38
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Sex-related difference in amygdala activity during emotionally influenced memory storage. Neurobiol Learn Mem (2001) 2.15
Report of the Institute of Medicine Committee on the Efficacy and Safety of Halcion. Arch Gen Psychiatry (1999) 2.03
Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry (1996) 1.84
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry (1993) 1.80
Diphtheria Studies: I-The Significance of the Schick Test in the Adult. Am J Public Health Nations Health (1934) 1.75
Diphtheria Immunization With Fluid Toxoid and Alum Precipitated Toxoid -Preliminary Report. Am J Public Health Nations Health (1939) 1.73
Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN study. Schizophr Bull (2009) 1.66
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology (2010) 1.63
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry (1982) 1.58
Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology (2006) 1.55
Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci (1996) 1.50
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group. Neuropsychopharmacology (1999) 1.45
Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression. Mol Psychiatry (2010) 1.42
Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry (2006) 1.38
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci U S A (2000) 1.37
Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry (1988) 1.36
GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex (1996) 1.31
Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry (1982) 1.30
Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry (1993) 1.30
Leukocytosis during lithium treatment. Am J Psychiatry (1971) 1.27
A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry (1983) 1.26
Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Sci (1989) 1.25
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia. Mol Psychiatry (2001) 1.25
Norepinephrine in depressive reactions. A review. Arch Gen Psychiatry (1965) 1.24
Stress-induced changes in primate prefrontal profiles of gene expression. Mol Psychiatry (2007) 1.18
Pertussis agglutinins in adults. Public Health Rep (1969) 1.16
Haloperidol concentrations elevated in Chinese patients. Psychiatry Res (1984) 1.14
Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry (1992) 1.13
Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry (1969) 1.13
Antibody response to booster dose of diphtheria and tetanus toxoids: Reactions in institutionalized adults and non-institutionalized children and young adults. Public Health Rep (1963) 1.13
Stimulation by lithium of monoamine uptake in human platelets. Life Sci (1969) 1.11
Quantitative studies of norepinephrine uptake by synaptosomes. Biochem Pharmacol (1968) 1.11
PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry (1996) 1.11
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial. Psychopharmacology (Berl) (2001) 1.11
Altered ratios of alternatively spliced long and short gamma2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci U S A (1998) 1.11
DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol Dis (2003) 1.10
Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet (1968) 1.09
Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry (1992) 1.08
The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep (1991) 1.07
A method for fixation of previously fresh-frozen human adult and fetal brains that preserves histological quality and immunoreactivity. J Neurosci Methods (1992) 1.07
L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biol Psychiatry (1970) 1.07
Naloxone alters pain perception and somatosensory evoked potentials in normal subjects. Nature (1977) 1.07
fMRI activity correlated with auditory hallucinations during performance of a working memory task: data from the FBIRN consortium study. Schizophr Bull (2008) 1.06
Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry (1992) 1.05
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03
The inheritance of affective disorders: a review of data and of hypotheses. Behav Genet (1976) 1.03
Seasonal affective disorder: prevalence varies with latitude and climate. Clin Neuropharmacol (1986) 1.03
Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol Psychiatry (2003) 1.03
Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) (1980) 1.02
Structured Interview for Assessing Perceptual Anomalies (SIAPA). Schizophr Bull (1999) 1.02
Relative sparing of emotionally influenced memory in Alzheimer's disease. Neuroreport (2000) 1.01
Lithium response in unipolar versus bipolar depression. Am J Psychiatry (1972) 1.01
The "switch process" in manic-depressive illness. II. Relationship to catecholamines, REM sleep, and drugs. Arch Gen Psychiatry (1972) 1.00
Age-related changes in sleep in depressed and normal subjects. Psychiatry Res (1981) 0.99
Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry (1993) 0.99
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia (1974) 0.98
A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia. Mol Psychiatry (2000) 0.98
S-adenosylmethionine blood levels in major depression: changes with drug treatment. Acta Neurol Scand Suppl (1994) 0.98
Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry (1996) 0.98
An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus. Am J Hum Genet (2000) 0.97
Pituitary adrenal function and depression. An outline for research. Arch Gen Psychiatry (1967) 0.97
Effect of L-DOPA on depression. Lancet (1969) 0.97
A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects. Arch Gen Psychiatry (1983) 0.97
Diphtheria Studies II-Use of Intradermal Injections of Toxin-Toxoid Mixtures in Diphtheria Immunization. Am J Public Health Nations Health (1935) 0.96
Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients. Arch Gen Psychiatry (1969) 0.96
Surgical stress in humans is accompanied by an increase in plasma beta-endorphin immunoreactivity. Life Sci (1981) 0.96
Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis. Arch Gen Psychiatry (2000) 0.95
Suicide prevention centers. Ecological study of effectiveness. J Nerv Ment Dis (1977) 0.95
Ageing, monoamines, and monoamine-oxidase levels. Lancet (1972) 0.95
Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res (1997) 0.95
Stability of exploratory eye movements as a marker of schizophrenia--a WHO multi-center study. World Health Organization. Schizophr Res (2001) 0.94
The "switch process" in manic-depressive illness. I. A systematic study of sequential behavioral changes. Arch Gen Psychiatry (1972) 0.93
Tardive dyskinesia--reversible and persistent. Arch Gen Psychiatry (1979) 0.93